Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-(bromomethyl)-1-chloro-3-iodobenzene is a halogenated aromatic compound with the molecular formula C7H5BrClI. It features a benzene ring with a chlorine atom, a bromomethyl group, and an iodine atom attached at different positions, making it a versatile building block in organic synthesis and pharmaceutical research.

1035263-31-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1035263-31-0 Structure
  • Basic information

    1. Product Name: 2-(bromomethyl)-1-chloro-3-iodobenzene
    2. Synonyms: 2-(bromomethyl)-1-chloro-3-iodobenzene
    3. CAS NO:1035263-31-0
    4. Molecular Formula:
    5. Molecular Weight: 331.378
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1035263-31-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-(bromomethyl)-1-chloro-3-iodobenzene(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-(bromomethyl)-1-chloro-3-iodobenzene(1035263-31-0)
    11. EPA Substance Registry System: 2-(bromomethyl)-1-chloro-3-iodobenzene(1035263-31-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1035263-31-0(Hazardous Substances Data)

1035263-31-0 Usage

Uses

Used in Organic Synthesis:
2-(bromomethyl)-1-chloro-3-iodobenzene is used as a building block for the synthesis of more complex molecules, due to its ability to undergo various chemical reactions to create diverse molecular structures.
Used in Pharmaceutical Research:
In the field of medicinal chemistry and drug development, 2-(bromomethyl)-1-chloro-3-iodobenzene is utilized as a key intermediate for the synthesis of pharmaceutical compounds, leveraging its unique structural features and reactivity.
Used in Chemical Industry:
The presence of different halogen atoms in 2-(bromomethyl)-1-chloro-3-iodobenzene makes it a valuable compound with potential applications in various fields of the chemical industry, including the production of specialty chemicals and materials.

Check Digit Verification of cas no

The CAS Registry Mumber 1035263-31-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,5,2,6 and 3 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1035263-31:
(9*1)+(8*0)+(7*3)+(6*5)+(5*2)+(4*6)+(3*3)+(2*3)+(1*1)=110
110 % 10 = 0
So 1035263-31-0 is a valid CAS Registry Number.

1035263-31-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(bromomethyl)-1-chloro-3-iodobenzene

1.2 Other means of identification

Product number -
Other names 2-Bromomethyl-1-chloro-3-iodo-benzene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1035263-31-0 SDS

1035263-31-0Relevant articles and documents

OXOACRIDINYL ACETIC ACID DERIVATIVES AND METHODS OF USE

-

Page/Page column 171, (2019/06/05)

Compounds of Formula I or pharmaceutically acceptable salts or esters thereof capable of binding to and modulating the activity of a stimulator of interferon genes (STING) protein are provided. Methods involving compounds of Formula I as effective modulators of STING are also provided.

Stereoretentive Intramolecular Glycosyl Cross-Coupling: Development, Scope, and Kinetic Isotope Effect Study

Yi, Duk,Zhu, Feng,Walczak, Maciej A.

supporting information, p. 4627 - 4631 (2018/08/07)

A series of cyclic C-glycosides were synthesized using the palladium-catalyzed stereoretentive intramolecular glycosylation of aryl iodides by employing a bulky phosphine ligand. A variety of functional groups are tolerated in the reaction, and enantioenr

A concise synthesis of chiral indanes as α1A adrenoceptor partial agonists

Roberts, Lee R.,Corbett, Matthew S.,Fussell, Steven J.,Hitzel, Laure,Jessiman, Alan S.,Mason, Helen J.,Osborne, Rachel,Ralph, Michael J.,Stennett, Adam S.D.,Wheeler, Simon,Storer, R. Ian

supporting information, p. 6546 - 6550 (2015/11/09)

The synthesis of a series of chiral indanes with reported α1A partial agonist activity is outlined, applying a rhodium catalysed cyclisation for template construction. This method was extended to the asymmetric synthesis of lead compound PF-037

DIFLUOROMETHYLENE COMPOUND

-

Paragraph 0404; 0405; 0897; 0898, (2015/06/16)

The present invention relates to a compound having an URAT1 inhibitory activity, and to an URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition containing the compound. More specifically, the present invention relates to a compound represented by the formula (I): wherein R1 is -Q1-A1 or the like; R2 is a hydrogen atom, a halogen atom, a lower alkyl group or the like; W1, W2, W3 and W4 are each independently a nitrogen atom or a methine group optionally having substituents, or the like; X and Y are each a single bond, an oxygen atom or the like; Z is a hydroxyl group or COOR3 or the like.

Novel 2-imidazoles as potent, selective and CNS penetrant α1A adrenoceptor partial agonists

Roberts, Lee R.,Bryans, Justin,Conlon, Kelly,McMurray, Gordon,Stobie, Alan,Whitlock, Gavin A.

scheme or table, p. 6437 - 6440 (2009/10/01)

A novel series of central nervous system (CNS) penetrant indane 2-imidazoles have been identified as potent, partial agonists of the α1A adrenergic receptor, having good selectivity over the α1B, α1D and α2 sub-

Synthesis and Structure of 1,7-Dichlorodibenzoheptalene-4,10-dione, a Saddle-Shaped Polycyclic Aromatic Compound

Pascal, Robert A.,Ho, Douglas M.

, p. 13 - 16 (2007/10/02)

We describe the synthesis and X-ray crystal structure of the title compound, which is the first fully unsaturated derivative of dibenzoheptalene to be prepared.The X-ray structure reveals a saddle-shaped molecule possessing approximate C2/sub

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1035263-31-0